Mark Birkenbach
Temple University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark Birkenbach.
Frontiers in Bioscience | 2015
M. Alexandra Monroy; Jianhua Fang; Shan Li; Lucas Ferrer; Mark Birkenbach; Iris Lee; Hong Wang; Xiao-Feng Yang; Eric T. Choi
Vascular access dysfunction associated with arteriovenous grafts and fistulas contributes to the morbidity and mortality of chronic kidney disease (CKD) patients receiving hemodialysis. We hypothesized that the uremic conditions associated with CKD promote a pathophysiological vascular smooth muscle cell (VSMC) phenotype that contributes to neointimal hyperplasia. We analyzed the effect of culturing human VSMC with uremic serum. Expression of VSMC contractile marker genes was reduced 50-80% in cells exposed to uremic serum and the decreased expression was accompanied by changes in histone marks. There was an increase in proliferation in cells exposed to uremic conditions, with no change in the levels of apoptosis. Interestingly, we found that uremic serum inhibited PDGF-induced migration of VSMC. Histomorphometric analysis revealed venous neointimal hyperplasia in veins from chronic kidney disease (CKD) patients prior to any surgical manipulation as compared to veins from patients with no kidney disease. We conclude that uremia associated with CKD alters VSMC phenotype in vitro and contributes to neointimal hyperplasia formation in vivo contributing to the pathogenesis of vascular access dysfunction in CKD patients.
Cancer Research | 2009
Denada Dibra; Jeffry Cutrera; Xueqing Xia; Mark Birkenbach; Shulin Li
It is well known that the interleukin (IL)-27 receptor WSX1 is expressed in immune cells and induces an IL-27-dependent immune response. Opposing this conventional dogma, this study reveals a much higher level of WSX1 expression in multiple types of epithelial tumor cells when compared with normal epithelial cells. Expression of exogenous WSX1 in epithelial tumor cells suppresses tumorigenicity in vitro and inhibits tumor growth in vivo. Different from the role of WSX1 in immune cells, the antitumor activity of WSX1 in epithelial tumor cells is independent of IL-27 signaling but is mainly dependent on natural killer (NK) cell surveillance. Deficiency of either the IL-27 subunit EBV-induced gene 3 or the IL-27 receptor WSX1 in the host animals had no effect on tumor growth inhibition induced by WSX1 expression in tumor cells. Expression of WSX1 in epithelial tumor cells enhances NK cell cytolytic activity against tumor cells, whereas the absence of functional NK cells impairs the WSX1-mediated inhibition of epithelial tumor growth. The underlying mechanism by which WSX1 expression in tumor cells enhances NK cytolytic activity is dependent on up-regulation of NKG2D ligand expression. Our results reveal an IL-27-independent function of WSX1: sensitizing NK cell-mediated antitumor surveillance via a NKG2D-dependent mechanism.
Clinical Immunology | 2010
Wen-Hai Shao; Yuxuan Zhen; Joshua Rosenbaum; Robert A. Eisenberg; Tracy L. McGaha; Mark Birkenbach; Philip L. Cohen
The Mer receptor tyrosine kinase is strongly expressed in the glomerulus. We wondered if this molecule might modify immune-mediated glomerular disease through its functions as a receptor for apoptotic cells and immunoregulatory molecule. Mer-knockout (KO) mice showed decreased survival rate and greatly increased proteinuria and serum urea levels compared to wild type (WT) mice by day 3 after injection of NTS. Their glomeruli were hyperplastic and later became necrotic. In the glomerulus of WT mice, a significant increase of Mer expression was observed. Apoptotic bodies were evident in NTS-treated Mer-KO kidneys, but not in normal controls. NTS-treated Mer-KO mice had massive neutrophil infiltration and inflammatory cytokine expression. Mer thus has a critical role in attenuating renal inflammation, both as a receptor for apoptotic cells and as a molecule that downregulates inflammation.
Jcr-journal of Clinical Rheumatology | 2013
Namrata Singh; Mark Birkenbach; Tiffany Caza; Andras Perl; Philip L. Cohen
AbstractTuberous sclerosis is an autosomal dominant disorder characterized by involvement of skin, nervous system, kidneys, and lungs. It results from mutations in 1 of 2 genes: TSC1 (encoding hamartin) or TSC2 (encoding tuberin), leading to dysregulation and activation of the mammalian target of rapamycin (mTOR) pathway. Constitutive activation of mTOR signaling has recently been reported in systemic lupus erythematosus (SLE), and inhibition of this pathway may benefit patients with SLE nephritis. We report a case of a young woman with tuberous sclerosis who developed fulminant SLE, with lower extremity edema, massive proteinuria, and class IV lupus glomerulonephritis. She died despite treatment with high-dose steroids, plasmapheresis, and cyclophosphamide. Although there are no prior reports of coexistence of these 2 rare diseases, this case is of considerable interest because of the possibility that activation of mTOR by the TSC mutations may have led to activation of the immune system and the development of unusually severe SLE.
PLOS Pathogens | 2013
Yeonseok Chung; Tomohide Yamazaki; Byung Seok Kim; Yongliang Zhang; Joseph M. Reynolds; Gustavo J. Martinez; Seon Hee Chang; Hoyong Lim; Mark Birkenbach; Chen Dong
Although the protective functions by T helper 17 (Th17) cytokines against extracellular bacterial and fungal infection have been well documented, their importance against intracellular bacterial infection remains unclear. Here, we investigated the contribution of Th17 responses to host defense against intracellular bacteria Listeria monocytogenes and found that Th17 cell generation was suppressed in this model. Unexpectedly, mice lacking both p35 and EBI3 cleared L. monocytogenes as efficiently as wild-type mice, whereas p35-deficient mice failed to do so. Furthermore, both innate cells and pathogen-specific T cells from double-deficient mice produced significantly higher IL-17 and IL-22 compared to wild-type mice. The bacterial burden in the liver of double-deficient mice treated with anti-IL-17 was significantly increased compared to those receiving a control Ab. Transfer of Th17 cells specific for listeriolysin O as well as administration of IL-17 and IL-22 significantly suppressed bacterial growth in p35-deficient mice, indicating the critical contribution of Th17 responses to host defense against the intracellular pathogen in the absence of IL-12 and proper Th1 responses. Our findings unveil a novel immune evasion mechanism whereby the intracellular bacteria exploit IL-27EBI3 to suppress Th17-mediated protective immunity.
Clinical Genitourinary Cancer | 2014
Scott Michael Norberg; Michelle Oros; Mark Birkenbach; Marijo Bilusic
Spontaneous tumor lysis syndrome (STLS) is a rare oncologic emergency caused by acute and massive death of tumor cells before the initiation of any anticancer therapy. It is commonly associated with aggressive hematological malignancies; however, it has been more frequently recognized in multiple solid tumors. Our literature search of STLS in solid tumors revealed common characteristics including extensive metastatic disease and increased levels of uric acid and lactate dehydrogenase. In this report, we describe, to our knowledge, the first case of STLS caused by a renal cell carcinoma and discuss the need for developing screening guidelines for this deadly syndrome.
Clinical Genitourinary Cancer | 2014
Scott Michael Norberg; Michelle Oros; Mark Birkenbach; Marijo Bilusic
Spontaneous tumor lysis syndrome (STLS) is a rare oncologic emergency caused by acute and massive death of tumor cells before the initiation of any anticancer therapy. It is commonly associated with aggressive hematological malignancies; however, it has been more frequently recognized in multiple solid tumors. Our literature search of STLS in solid tumors revealed common characteristics including extensive metastatic disease and increased levels of uric acid and lactate dehydrogenase. In this report, we describe, to our knowledge, the first case of STLS caused by a renal cell carcinoma and discuss the need for developing screening guidelines for this deadly syndrome.
Clinical Genitourinary Cancer | 2014
Scott Michael Norberg; Michelle Oros; Mark Birkenbach; Marijo Bilusic
Spontaneous tumor lysis syndrome (STLS) is a rare oncologic emergency caused by acute and massive death of tumor cells before the initiation of any anticancer therapy. It is commonly associated with aggressive hematological malignancies; however, it has been more frequently recognized in multiple solid tumors. Our literature search of STLS in solid tumors revealed common characteristics including extensive metastatic disease and increased levels of uric acid and lactate dehydrogenase. In this report, we describe, to our knowledge, the first case of STLS caused by a renal cell carcinoma and discuss the need for developing screening guidelines for this deadly syndrome.
Dialysis & Transplantation | 2011
Nicole M. Sifontis; Richard Kim; Mark Birkenbach; Iris Lee; Serban Constantinescu; Andreas Karachristos; Patricio Silva; John A. Daller
Clinical Transplantation | 2009
Iris Lee; Serban Constantinescu; Avrum Gillespie; Abhishek Swami; Mark Birkenbach; Stephen H. Leech; Patricio Silva; Andreas Karachristos; John A. Daller; Nicole M. Sifontis